ArticleBMC medical imaging2025
Comparative study for CT-guided
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Current Treatment Options and Emerging Technologies for Pelvic Bone Tumors: From Limb Salvage to Precision Oncology.Current treatment options in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study compared the outcomes of modified three-dimensional printed non-coplanar templates (3DPNCT) with those of conventional 3DPNCT for iodine-125 ( MATERIAL AND
methodsWe analyzed patients with malignant tumors undergoing
resultsA total of 70 patients were enrolled, including 35 in the experimental group and 35 in the control group. In the experimental group, pre- and post-operation values for PTV, D
conclusionsThe modified 3DPNCT improved consistency between pre- and post-operative dose parameters in comparison to the conventional 3DPNCT and showed the potential to deliver a higher dose to the tumor. This innovative 3DPNCT provides enhanced adaptability for intraoperative needle adjustments during seed implantation therapies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.